Evidence map›Paper›PMID 29332214›Full record

ArticlePediatric cardiology2018

Targeted Next-Generation Sequencing in Patients with Non-syndromic Congenital Heart Disease.

Silvia Pulignani, Cecilia Vecoli, Andrea Borghini, Ilenia Foffa, Lamia Ait-Alì, Maria Grazia Andreassi

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genes · 2024
    Article
  7. Article
  8. Human Genetics of Ventricular Septal Defect.Advances in experimental medicine and biology · 2024
    Article
  9. Article
  10. Significance of α-Myosin Heavy Chain (Journal of cardiovascular development and disease · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Silvia PulignaniCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124, Pisa, Italy. pulignani@ifc.cnr.it.
Cecilia VecoliCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124, Pisa, Italy.
Andrea BorghiniCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124, Pisa, Italy.
Ilenia FoffaCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124, Pisa, Italy.
Lamia Ait-AlìCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124, Pisa, Italy.
Maria Grazia AndreassiCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124, Pisa, Italy.
Istituto di Fisiologia Clinica · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital heart disease (CHD) is a genetically heterogeneous disease. Targeted next-generation sequencing (NGS) offers a unique opportunity to sequence multiple genes at lower cost and effort compared to Sanger sequencing. We tested a targeted NGS of a specific gene panel in a relatively large population of non-syndromic CHD patients. The patient cohort comprised 68 CHD patients (45 males; 8.3 ± 1.7 years). Amplicon libraries for 16 CHD-strictly related genes were generated using a TruSeq

Indexed as

AdolescentAllelesChildFemaleGene FrequencyHeart Defects, CongenitalHigh-Throughput Nucleotide SequencingHumansMaleMutationCongenital heart diseaseGene panelNext-generation sequencingSingle-nucleotide variants

Identifiers

PMID29332214
OpenAlexW2783535096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.